🍽️ d-trehalose (sugar)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of d-trehalose (sugar) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by d-trehalose (sugar)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Rhodocyclaceae family Increases ⚗️ Source Study
Peptostreptococcaceae family Increases 📓 Source Study
Paraclostridium genus Decreases 👶 Source Study
Thalassospira genus Increases ⚗️ Source Study
Gallicola genus Increases ⚗️ Source Study
Acetoanaerobium genus Increases 👶 Source Study
Asaccharospora genus Increases 👶 Source Study
Clostridioides genus Increases 👶 Source Study
Criibacterium genus Increases 👶 Source Study
Filifactor genus Increases 👶 Source Study
Intestinibacter genus Increases 👶 Source Study
Paeniclostridium genus Increases 👶 Source Study
Peptacetobacter genus Increases 👶 Source Study
Peptoanaerobacter genus Increases 👶 Source Study
Peptoclostridium genus Increases 👶 Source Study
Peptostreptococcus genus Increases 👶 Source Study Pathogen
Proteocatella genus Increases 👶 Source Study
Romboutsia genus Increases 👶 Source Study
Sporacetigenium genus Increases 👶 Source Study
Tepidibacter genus Increases 👶 Source Study
Terrisporobacter genus Increases 👶 Source Study
Clostridioides genus Increases 📓 Source Study
Peptoclostridium genus Increases 📓 Source Study
Peptostreptococcaceae incertae sedis no rank Increases 👶 Source Study
unclassified Clostridioides no rank Increases 👶 Source Study
unclassified Peptostreptococcaceae no rank Increases 👶 Source Study
Allisonella histaminiformans species Increases ⚗️ Source Study
Clostridioides aff. difficile AA1 species Increases 👶 Source Study
Clostridioides difficile species Increases 👶 Source Study Colitis
Clostridioides mangenotii species Increases 👶 Source Study
Peptoclostridium acidaminophilum species Increases 👶 Source Study
Peptoclostridium litorale species Increases 👶 Source Study
Asaccharospora irregularis species Increases ⚗️ Source Study
Clostridioides difficile species Increases 📓 Source Study Colitis
Clostridioides difficile 002-P50-2011 strain Increases 👶 Source Study
Clostridioides difficile 2007855 strain Increases 👶 Source Study
Clostridioides difficile 342 strain Increases 👶 Source Study
Clostridioides difficile 6041 strain Increases 👶 Source Study
Clostridioides difficile 630 strain Increases 👶 Source Study H00338 Pseudomembranous colitis
Clostridioides difficile ATCC 43255 strain Increases 👶 Source Study
Clostridioides difficile ATCC 9689 = DSM 1296 strain Increases 👶 Source Study
Clostridioides difficile BI9 strain Increases 👶 Source Study
Clostridioides difficile BJ08 strain Increases 👶 Source Study
Clostridioides difficile CD196 strain Increases 👶 Source Study H00338 Pseudomembranous colitis
Clostridioides difficile CD40 strain Increases 👶 Source Study
Clostridioides difficile DA00195 strain Increases 👶 Source Study
Clostridioides difficile E85 strain Increases 👶 Source Study
Clostridioides difficile F321 strain Increases 👶 Source Study
Clostridioides difficile F501 strain Increases 👶 Source Study
Clostridioides difficile genomovar ribotype_087 strain Increases 👶 Source Study
Clostridioides difficile M120 strain Increases 👶 Source Study
Clostridioides difficile NAP08 strain Increases 👶 Source Study
Clostridioides difficile P28 strain Increases 👶 Source Study
Clostridioides difficile P29 strain Increases 👶 Source Study
Clostridioides difficile P38 strain Increases 👶 Source Study
Clostridioides difficile P51 strain Increases 👶 Source Study
Clostridioides difficile QCD-23m63 strain Increases 👶 Source Study
Clostridioides difficile QCD-37x79 strain Increases 👶 Source Study
Clostridioides difficile QCD-63q42 strain Increases 👶 Source Study
Clostridioides difficile QCD-76w55 strain Increases 👶 Source Study

Impact of d-trehalose (sugar) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Allergies 0.4 -0.4
Alzheimer's disease 0.8 0.2 3
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.2 0.2
Autism 0.6 -0.6
Breast Cancer 0.2 0.2
Chronic Fatigue Syndrome 0.2 -0.2
Chronic Kidney Disease 0.2 0.2
Chronic Obstructive Pulmonary Disease (COPD) 0.4 -0.4
Colorectal Cancer 0.2 -0.2
COVID-19 0.2 0.6 -2
Crohn's Disease 0.2 0.2 0
Depression 0.2 -0.2
Eczema 0.2 -0.2
Eosinophilic Esophagitis 0.2 0.2
Glioblastoma 0.6 -0.6
Graves' disease 0.6 0.6
Halitosis 0.2 -0.2
Hashimoto's thyroiditis 0.2 -0.2
hypertension (High Blood Pressure 0.2 0.2
Inflammatory Bowel Disease 0.2 -0.2
Long COVID 1 1.4 -0.4
Metabolic Syndrome 0.8 0.8
Mood Disorders 0.3 1.2 -3
Multiple Sclerosis 0.2 0.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.6 0.6 0
Obesity 0.2 -0.2
obsessive-compulsive disorder 0.2 0.4 -1
Parkinson's Disease 0.4 -0.4
Psoriasis 0.2 0.2 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.8 0.6 0.33
Schizophrenia 0.3 1 -2.33
Sleep Apnea 0.6 -0.6
Stress / posttraumatic stress disorder 0.2 -0.2
Tic Disorder 0.1 0.1
Type 1 Diabetes 0.2 0.2
Type 2 Diabetes 0.6 0.6
Ulcerative colitis 0.2 -0.2
Unhealthy Ageing 0.4 -0.4

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)